ロード中...
A single proteolytic cleavage within the lower hinge of trastuzumab reduces immune effector function and in vivo efficacy
INTRODUCTION: Recent studies reported that human IgG antibodies are susceptible to specific proteolytic cleavage in their lower hinge region, and the hinge cleavage results in a loss of Fc-mediated effector functions. Trastuzumab is a humanized IgG(1 )therapeutic monoclonal antibody for the treatmen...
保存先:
| 主要な著者: | , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2012
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3680949/ https://ncbi.nlm.nih.gov/pubmed/22873525 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr3240 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|